Study in Healthy Males to Measure Maraviroc in Blood, Saliva, Seminal Fluid, and Rectal Tissue

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

March 31, 2010

Conditions
HIV/AIDS
Interventions
DRUG

Maraviroc

Healthy male volunteers will take maraviroc 300 mg orally twice daily for 15 doses (8 days)

Trial Locations (1)

27514

UNC Hospitals CTRC, Chapel Hill

Sponsors

Collaborators (1)

All Listed Sponsors
lead

University of North Carolina, Chapel Hill

OTHER

collaborator

Pfizer

INDUSTRY